NMRA-094

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameNMRA-094
Drug Alias NameNMRA094
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor modulatorsSerotonin 2a (5-HT2a) receptor modulators
TargetsSerotonin 2a (5-HT2a) receptorHistamine H1 receptor
Therapy Area/IndicationsSleep Wake Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRein Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeumora Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSleep Wake Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A